Acuta Capital Partners’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,575	Closed	-$153K	–	38
2023 Q1	$153K	Sell	3,575 -76,425	-96%	-$3.26M	0.11%	30
2022 Q4	$3.84M	Buy	+80,000	New	+$3.84M	2.36%	19